ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,171,000 | -70.5% | 10,287 | -64.1% | 0.04% | -70.3% |
| Q4 2020 | $3,972,000 | +71.7% | 28,689 | +1.9% | 0.14% | +45.0% |
| Q3 2020 | $2,313,000 | +10.8% | 28,143 | +5.5% | 0.10% | +8.7% |
| Q2 2020 | $2,087,000 | +57.9% | 26,684 | -10.3% | 0.09% | +46.0% |
| Q1 2020 | $1,322,000 | +5.8% | 29,754 | +1.6% | 0.06% | +80.0% |
| Q4 2019 | $1,250,000 | -2.0% | 29,278 | -1.9% | 0.04% | +2.9% |
| Q3 2019 | $1,276,000 | -25.0% | 29,836 | +11.3% | 0.03% | -20.9% |
| Q2 2019 | $1,702,000 | -2.0% | 26,803 | +7.1% | 0.04% | -2.3% |
| Q1 2019 | $1,736,000 | +59.6% | 25,029 | 0.0% | 0.04% | +57.1% |
| Q4 2018 | $1,088,000 | -44.9% | 25,029 | -3.1% | 0.03% | -40.4% |
| Q3 2018 | $1,973,000 | -9.5% | 25,840 | -8.9% | 0.05% | -9.6% |
| Q2 2018 | $2,179,000 | -5.4% | 28,353 | -37.2% | 0.05% | -11.9% |
| Q1 2018 | $2,304,000 | +13.6% | 45,178 | +3.3% | 0.06% | +11.3% |
| Q4 2017 | $2,028,000 | -20.5% | 43,733 | -8.7% | 0.05% | -19.7% |
| Q3 2017 | $2,551,000 | +4.2% | 47,895 | +21.5% | 0.07% | -5.7% |
| Q2 2017 | $2,449,000 | – | 39,425 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |